Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC)

313 filings reported holding BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share as of Q2 2021.
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) has 271 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 58,476,330 shares of 65,000,000 outstanding shares and own 89.96% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5,565,543 shares), BlackRock Inc. (5,185,918 shares), PRICE T ROWE ASSOCIATES INC /MD/ (4,262,114 shares), FMR LLC (4,250,125 shares), WELLINGTON MANAGEMENT GROUP LLP (2,016,062 shares), STATE STREET CORP (1,649,246 shares), TimesSquare Capital Management, LLC (1,575,095 shares), JPMORGAN CHASE & CO (1,569,896 shares), Casdin Capital, LLC (1,550,000 shares), and ALLIANCEBERNSTEIN L.P. (1,402,239 shares).
This table shows the top 271 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.